{"id":19515,"date":"2021-04-20T14:51:19","date_gmt":"2021-04-20T12:51:19","guid":{"rendered":"https:\/\/vilkaviskiovsb.lt\/?p=19515"},"modified":"2021-04-20T14:51:19","modified_gmt":"2021-04-20T12:51:19","slug":"i-lietuva-pristatyta-vienuoliktoji-vaxzevria-vakcinu-siunta","status":"publish","type":"post","link":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/2021\/04\/20\/i-lietuva-pristatyta-vienuoliktoji-vaxzevria-vakcinu-siunta\/","title":{"rendered":"\u012e Lietuv\u0105 pristatyta vienuoliktoji \u201eVaxzevria\u201c vakcin\u0173 siunta"},"content":{"rendered":"

Antradien\u012f Lietuv\u0105 pasiek\u0117 vienuoliktoji \u201eVaxzevria\u201c (gamintojas \u201eAstraZeneca\u201c) vakcin\u0173 nuo koronaviruso (COVID-19) siunta, kuri\u0105 sudaro 19200 vakcinos dozi\u0173. Per kelias dienas jos pasieks savivaldybes.<\/strong><\/p>\n

Iki \u0161ios dienos Lietuva gavo 202,1 t\u016bkst. \u201eVaxzevria\u201c vakcinos dozi\u0173, o gyventoj\u0173 skiepijimui sunaudota 188,3 t\u016bkst.<\/p>\n

\u201eVaxzevria\u201c vakcina yra skiepijama dviem doz\u0117mis, tarp j\u0173 darant 4\u201312 savai\u010di\u0173 pertrauk\u0105. Svarbu pa\u017eym\u0117ti, kad po ilgesn\u0117s pertraukos tarp dozi\u0173 formuojasi daugiau antik\u016bn\u0173 ir tvirtesnis imunitetas, tod\u0117l Sveikatos apsaugos ministerija (SAM) rekomenduoja taikyti maksimali\u0105 12 savai\u010di\u0173 pertrauk\u0105.<\/p>\n

Atsi\u017evelgdamos \u012f pacient\u0173 individualias aplinkybes, jeigu ilgesn\u0117 pertrauka tur\u0117s neigiamos \u012ftakos j\u0173 vykdomai veiklai, skiepijan\u010dios \u012fstaigos gali pasi\u016blyti trumpesn\u012f laiko tarp\u0105 tarp pirmos ir antros vakcinos doz\u0117s, bet jis negali b\u016bti trumpesnis nei 4 savait\u0117s. SAM rekomenduoja trumpesn\u0119 pertrauk\u0105 taikyti abiturientams ir mokytojams, taip pat periodi\u0161kai testuotis turin\u010dioms asmen\u0173 grup\u0117ms.<\/p>\n

I\u0161 viso vakcinomis nuo COVID-19 Lietuvoje jau paskiepyta 569,8 t\u016bkst. gyventoj\u0173, arba 20,4 proc. visuomen\u0117s. Dviem vakcinos doz\u0117mis yra vakcinuota 210,6 t\u016bkst. \u017emoni\u0173, arba 7,5 proc. \u0161alies gyventoj\u0173.<\/p>\n

I\u0161samesn\u0117 vakcinacijos statistika yra pateikiama Statistikos departamento \u0161vieslent\u0117je<\/a>.<\/p>\n

\u012e Lietuv\u0105 atvykus naujoms vakcin\u0173 siuntoms, informacija apie jas yra atnaujinama Sveikatos apsaugos ministerijos interneto svetain\u0117je<\/a>.<\/p>\n

Gyventoj\u0173 vakcinacijos plan\u0105 ir kit\u0105 aktuali\u0105 informacij\u0105 apie vakcinas rasite interneto svetain\u0117je Koronastop.lt<\/a>.<\/p>\n

SAM Spaudos tarnyba<\/em><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Antradien\u012f Lietuv\u0105 pasiek\u0117 vienuoliktoji \u201eVaxzevria\u201c (gamintojas \u201eAstraZeneca\u201c) vakcin\u0173 nuo koronaviruso (COVID-19) siunta, kuri\u0105 sudaro 19200 vakcinos dozi\u0173. Per kelias dienas jos pasieks savivaldybes. Iki \u0161ios dienos Lietuva gavo 202,1 t\u016bkst. \u201eVaxzevria\u201c vakcinos dozi\u0173, o gyventoj\u0173 skiepijimui sunaudota 188,3 t\u016bkst. \u201eVaxzevria\u201c vakcina yra skiepijama dviem doz\u0117mis, tarp j\u0173 darant 4\u201312 savai\u010di\u0173 pertrauk\u0105. Svarbu pa\u017eym\u0117ti, kad po…<\/p>\n","protected":false},"author":3,"featured_media":19165,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[100],"tags":[],"class_list":["post-19515","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-del-covid-19","category-100","description-off"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p7kWFe-54L","jetpack_featured_media_url":"https:\/\/vilkaviskiovsb.lt\/wp-content\/uploads\/2021\/03\/18826_ee0391e89ed8f07553c817760fd37cf2.jpg","post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts\/19515","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/comments?post=19515"}],"version-history":[{"count":1,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts\/19515\/revisions"}],"predecessor-version":[{"id":19516,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts\/19515\/revisions\/19516"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/media\/19165"}],"wp:attachment":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/media?parent=19515"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/categories?post=19515"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/tags?post=19515"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}